Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1369, doi:10.1016/j.jacc.2007.01.010 (Published online 7 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.01.010v1
49/12/1369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Pepine, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Pepine, C. J.
Related Collections
Right arrowRelated Articles

CORRESPONDENCE: LETTER TO THE EDITOR

Blood Pressure Levels on Progression of Coronary Atherosclerosis

Franz H. Messerli, MD*, Giuseppe Mancia, MD, C. Richard Conti, MD and Carl J. Pepine, MD

* St. Luke’s–Roosevelt Hospital Center, Division of Cardiology, 1000 Tenth Avenue, 3B-30, New York, New York 10019 (Email: fmesserli{at}aol.com).


The provocative study by Sipahi et al. (1) looking at progressions of coronary artery disease (CAD) in hypertension by intravascular ultrasound (IVUS) and the accompanying editorial by Tobis and Fonarow (2) do not quite clearly distinguish between the effects of blood pressure (BP) lowering on prevention or progression of CAD and the effects of BP lowering as a treatment modality in patients with manifest CAD. There is little surprise that the lower the BP, the better CAD will be prevented or its progression reversed. Numerous clinical and experimental low BP models are characterized by little, if any, atheromatosis in the exposed vascular bed. In fact, to put it pointedly, a zero BP would probably eliminate CAD completely. However, in patients with established CAD, several studies have shown that lowering diastolic pressure below certain levels will increase the risk of acute coronary events.

Based on our recent findings of a subanalysis of the 22,000-patient INVEST (International Verapamil-Trandolapril Study) (3), we would like to caution about too aggressive BP lowering in hypertensive patients with CAD. This holds particularly true for diastolic pressure and less so for systolic pressure. In the INVEST study (3), the nadir for primary outcome (all-cause death and total myocardial infarction) was J-shaped, with a nadir at 119/84 mm Hg (3). When diastolic pressure dropped below 70 mm Hg the adjusted hazard ratio of primary outcome doubled, and below 60 mm Hg it quadrupled. Because the coronary arteries are perfused during diastole only, coronary perfusion may become hampered when diastolic pressure falls excessively in patients at risk (i.e., those with CAD). Of note, in the study by Sipahi et al. (1) only systolic but not diastolic pressure was a significant determinant of progression of CAD. Thus, their concluding statement that "the most favorable rate of progression of coronary atherosclerosis is observed in patients whose BP falls within the "normal" Joint National Commission-7 category (i.e., systolic BP <120 mm Hg and diastolic BP <80 mm Hg)" and that "the optimal BP goal may be substantially lower than the <140/90 mm Hg" should be amended by refraining from identifying any levels of diastolic pressure.


    References
 Top
 References
 
1. Sipahi I, Tuzcu EM, Schoenhagen P, et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis J Am Coll Cardiol 2006;48:833-838.[Abstract/Free Full Text]

2. Tobis J, Fonarow GC. Optimal blood pressure levels in patients with coronary artery disease J Am Coll Cardiol 2006;48:839-840.[Free Full Text]

3. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-893.[Abstract/Free Full Text]


Related Articles

Blood Pressure Levels on Progression of Coronary Atherosclerosis
Franz H. Messerli, Giuseppe Mancia, C. Richard Conti, and Carl J. Pepine
J. Am. Coll. Cardiol. 2007 49: 1369. [Full Text] [PDF]

Reply
Ilke Sipahi, E. Murat Tuzcu, and Steven E. Nissen
J. Am. Coll. Cardiol. 2007 49: 1369-1370. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.01.010v1
49/12/1369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Pepine, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messerli, F. H.
Right arrow Articles by Pepine, C. J.
Related Collections
Right arrowRelated Articles

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement